Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nr2c2
|
ENSMUSG00000005893.8 | nuclear receptor subfamily 2, group C, member 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_92091630_92092420 | Nr2c2 | 408 | 0.826997 | 0.34 | 1.2e-02 | Click! |
chr6_92091029_92091529 | Nr2c2 | 111 | 0.961618 | 0.25 | 6.3e-02 | Click! |
chr6_92092496_92092686 | Nr2c2 | 158 | 0.948639 | -0.04 | 7.8e-01 | Click! |
chr6_92153968_92154119 | Nr2c2 | 2938 | 0.203368 | 0.00 | 1.0e+00 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chrX_169997850_169998483 | 13.09 |
Gm15247 |
predicted gene 15247 |
11227 |
0.14 |
chrY_90771840_90772811 | 12.75 |
Gm47283 |
predicted gene, 47283 |
12413 |
0.17 |
chr2_153492229_153493481 | 9.32 |
4930404H24Rik |
RIKEN cDNA 4930404H24 gene |
65 |
0.82 |
chr15_98608664_98610204 | 8.80 |
Adcy6 |
adenylate cyclase 6 |
598 |
0.55 |
chr1_166002288_166003185 | 8.28 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr16_38294342_38294493 | 8.03 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
407 |
0.8 |
chr17_49305203_49305406 | 7.96 |
Gm17830 |
predicted gene, 17830 |
6937 |
0.19 |
chr8_117718550_117718744 | 7.74 |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
2289 |
0.22 |
chr2_145822802_145822960 | 7.74 |
Rin2 |
Ras and Rab interactor 2 |
592 |
0.78 |
chr8_120486990_120488549 | 7.72 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
678 |
0.64 |
chr14_48475621_48476075 | 7.59 |
Tmem260 |
transmembrane protein 260 |
3526 |
0.2 |
chr11_98446586_98447075 | 7.53 |
Grb7 |
growth factor receptor bound protein 7 |
4 |
0.95 |
chr19_4024416_4024567 | 7.45 |
Gstp1 |
glutathione S-transferase, pi 1 |
11502 |
0.06 |
chr2_173152672_173153088 | 7.37 |
Pck1 |
phosphoenolpyruvate carboxykinase 1, cytosolic |
168 |
0.95 |
chr11_35732476_35732633 | 7.18 |
Pank3 |
pantothenate kinase 3 |
36930 |
0.14 |
chr16_4012853_4013176 | 6.99 |
Slx4 |
SLX4 structure-specific endonuclease subunit homolog (S. cerevisiae) |
9244 |
0.1 |
chr15_83223251_83223918 | 6.94 |
A4galt |
alpha 1,4-galactosyltransferase |
28145 |
0.1 |
chr15_99718561_99719052 | 6.90 |
Gpd1 |
glycerol-3-phosphate dehydrogenase 1 (soluble) |
1190 |
0.23 |
chr2_131222259_131222421 | 6.70 |
Mavs |
mitochondrial antiviral signaling protein |
11723 |
0.1 |
chr2_155604966_155605247 | 6.63 |
Myh7b |
myosin, heavy chain 7B, cardiac muscle, beta |
6106 |
0.08 |
chr14_54383598_54383819 | 6.60 |
Slc7a7 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 |
459 |
0.67 |
chr11_109485500_109485651 | 6.52 |
Arsg |
arylsulfatase G |
31 |
0.96 |
chr19_10657832_10658033 | 6.47 |
Vwce |
von Willebrand factor C and EGF domains |
57 |
0.95 |
chr2_69897352_69898558 | 6.35 |
Ubr3 |
ubiquitin protein ligase E3 component n-recognin 3 |
652 |
0.6 |
chr10_127508848_127510720 | 6.31 |
Stac3 |
SH3 and cysteine rich domain 3 |
2559 |
0.15 |
chr8_35564084_35564246 | 6.24 |
Mfhas1 |
malignant fibrous histiocytoma amplified sequence 1 |
23633 |
0.16 |
chr4_138342781_138342970 | 6.13 |
Cda |
cytidine deaminase |
774 |
0.5 |
chr9_110343931_110344181 | 6.11 |
Scap |
SREBF chaperone |
143 |
0.93 |
chr11_101556560_101556853 | 6.06 |
Nbr1 |
NBR1, autophagy cargo receptor |
534 |
0.6 |
chr2_84810833_84811663 | 6.06 |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
5019 |
0.11 |
chr17_5893214_5893395 | 6.05 |
Gm8376 |
predicted gene 8376 |
45783 |
0.1 |
chr5_66054485_66054755 | 6.02 |
Rbm47 |
RNA binding motif protein 47 |
68 |
0.96 |
chr5_36724217_36724614 | 6.02 |
Gm43701 |
predicted gene 43701 |
24203 |
0.11 |
chr3_19962855_19963059 | 5.93 |
Cp |
ceruloplasmin |
5673 |
0.19 |
chr1_180821249_180821410 | 5.92 |
H3f3a |
H3.3 histone A |
7386 |
0.1 |
chr11_8504165_8504360 | 5.88 |
Tns3 |
tensin 3 |
35587 |
0.23 |
chr5_114826015_114826186 | 5.81 |
1500011B03Rik |
RIKEN cDNA 1500011B03 gene |
2632 |
0.12 |
chr14_76567307_76567607 | 5.74 |
Serp2 |
stress-associated endoplasmic reticulum protein family member 2 |
10568 |
0.2 |
chr6_38881573_38881724 | 5.69 |
Hipk2 |
homeodomain interacting protein kinase 2 |
5483 |
0.22 |
chr7_46833351_46833657 | 5.68 |
Gm45308 |
predicted gene 45308 |
1040 |
0.32 |
chr7_128288334_128288485 | 5.58 |
Mir3103 |
microRNA 3103 |
26 |
0.79 |
chr7_35167963_35168328 | 5.55 |
Slc7a10 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 |
18240 |
0.1 |
chr6_136647483_136647837 | 5.51 |
Plbd1 |
phospholipase B domain containing 1 |
13102 |
0.15 |
chr7_100500401_100501097 | 5.46 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
2403 |
0.14 |
chr14_30875458_30875850 | 5.44 |
Stimate |
STIM activating enhancer |
3299 |
0.15 |
chr5_65350579_65350731 | 5.41 |
Klb |
klotho beta |
2247 |
0.19 |
chr11_102364061_102364256 | 5.37 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
454 |
0.69 |
chr5_66052662_66053184 | 5.30 |
Rbm47 |
RNA binding motif protein 47 |
1629 |
0.27 |
chr10_115817172_115817352 | 5.27 |
Tspan8 |
tetraspanin 8 |
9 |
0.99 |
chr4_136186846_136187035 | 5.26 |
E2f2 |
E2F transcription factor 2 |
6157 |
0.15 |
chr12_83579151_83579469 | 5.25 |
Zfyve1 |
zinc finger, FYVE domain containing 1 |
16377 |
0.14 |
chr8_5030765_5030932 | 5.23 |
n-R5s93 |
nuclear encoded rRNA 5S 93 |
38529 |
0.14 |
chr11_95320033_95320337 | 5.22 |
Gm11520 |
predicted gene 11520 |
9756 |
0.12 |
chr5_139738871_139739112 | 5.22 |
Micall2 |
MICAL-like 2 |
2655 |
0.2 |
chr16_46507399_46507598 | 5.20 |
Nectin3 |
nectin cell adhesion molecule 3 |
8973 |
0.26 |
chr18_62176881_62177064 | 5.18 |
Adrb2 |
adrenergic receptor, beta 2 |
2987 |
0.24 |
chr8_46446013_46446209 | 5.17 |
Gm45245 |
predicted gene 45245 |
6193 |
0.16 |
chr10_30763229_30763567 | 5.16 |
Gm48334 |
predicted gene, 48334 |
6177 |
0.15 |
chr7_19965148_19965499 | 5.16 |
Ceacam20 |
carcinoembryonic antigen-related cell adhesion molecule 20 |
89 |
0.93 |
chr19_4593871_4594048 | 5.14 |
Pcx |
pyruvate carboxylase |
387 |
0.78 |
chr8_69063512_69063903 | 5.11 |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
11801 |
0.15 |
chr3_104671656_104671921 | 5.10 |
Gm29560 |
predicted gene 29560 |
1778 |
0.2 |
chr8_23246177_23246339 | 5.10 |
Golga7 |
golgi autoantigen, golgin subfamily a, 7 |
1080 |
0.39 |
chr2_165884402_165885933 | 5.09 |
Zmynd8 |
zinc finger, MYND-type containing 8 |
293 |
0.86 |
chr7_45728040_45728346 | 5.09 |
Fam83e |
family with sequence similarity 83, member E |
2334 |
0.1 |
chr9_15535486_15535776 | 5.08 |
Smco4 |
single-pass membrane protein with coiled-coil domains 4 |
14772 |
0.16 |
chr4_150220682_150221014 | 5.05 |
Gm13094 |
predicted gene 13094 |
7187 |
0.14 |
chr5_93296593_93296768 | 5.04 |
Ccng2 |
cyclin G2 |
27972 |
0.16 |
chr3_131263877_131264074 | 5.03 |
Hadh |
hydroxyacyl-Coenzyme A dehydrogenase |
8049 |
0.16 |
chr11_102241268_102241471 | 5.03 |
Hrob |
homologous recombination factor with OB-fold |
7513 |
0.09 |
chr4_80949512_80949709 | 5.02 |
Gm27452 |
predicted gene, 27452 |
17834 |
0.24 |
chr4_9781508_9781669 | 5.00 |
4930412C18Rik |
RIKEN cDNA 4930412C18 gene |
10791 |
0.23 |
chr19_32180169_32180459 | 4.98 |
Sgms1 |
sphingomyelin synthase 1 |
16114 |
0.21 |
chr1_182268291_182268667 | 4.95 |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
13745 |
0.17 |
chr3_89136366_89136871 | 4.95 |
Pklr |
pyruvate kinase liver and red blood cell |
5 |
0.94 |
chr17_5798459_5798854 | 4.94 |
3300005D01Rik |
RIKEN cDNA 3300005D01 gene |
1 |
0.97 |
chr4_133872994_133873306 | 4.94 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
111 |
0.88 |
chr12_110232020_110232223 | 4.94 |
Gm40576 |
predicted gene, 40576 |
4241 |
0.13 |
chr11_119428857_119429280 | 4.93 |
Rnf213 |
ring finger protein 213 |
35968 |
0.11 |
chr11_107337371_107337788 | 4.93 |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
53 |
0.88 |
chr5_114968675_114969360 | 4.92 |
Hnf1aos2 |
HNF1 homeobox A, opposite strand 2 |
194 |
0.52 |
chr7_141094595_141095097 | 4.91 |
Sigirr |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
45 |
0.94 |
chr6_141615453_141615641 | 4.90 |
Slco1b2 |
solute carrier organic anion transporter family, member 1b2 |
13971 |
0.25 |
chr4_135958432_135958739 | 4.88 |
Hmgcl |
3-hydroxy-3-methylglutaryl-Coenzyme A lyase |
1142 |
0.29 |
chr18_68199215_68199539 | 4.87 |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
28690 |
0.15 |
chr5_107236924_107237265 | 4.85 |
Gm8145 |
predicted gene 8145 |
4529 |
0.18 |
chr5_134313726_134314672 | 4.84 |
Gtf2i |
general transcription factor II I |
179 |
0.92 |
chr11_4998343_4998516 | 4.84 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
11045 |
0.13 |
chr7_135521666_135522037 | 4.84 |
Clrn3 |
clarin 3 |
6803 |
0.18 |
chr11_58643382_58643689 | 4.84 |
Trim58 |
tripartite motif-containing 58 |
3070 |
0.1 |
chr12_84962629_84962792 | 4.83 |
Arel1 |
apoptosis resistant E3 ubiquitin protein ligase 1 |
3320 |
0.17 |
chr9_70834749_70835115 | 4.80 |
Gm3436 |
predicted pseudogene 3436 |
17644 |
0.18 |
chr13_37940347_37940527 | 4.79 |
Rreb1 |
ras responsive element binding protein 1 |
6579 |
0.22 |
chr8_34097215_34097650 | 4.79 |
Dctn6 |
dynactin 6 |
259 |
0.86 |
chr2_128612336_128612537 | 4.77 |
Gm39929 |
predicted gene, 39929 |
2806 |
0.17 |
chr2_174329445_174331091 | 4.76 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
19 |
0.97 |
chr6_124481595_124482129 | 4.75 |
C1rl |
complement component 1, r subcomponent-like |
11251 |
0.09 |
chr10_40077698_40077860 | 4.73 |
Slc16a10 |
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
1174 |
0.41 |
chr11_115899580_115900578 | 4.72 |
Smim5 |
small integral membrane protein 5 |
99 |
0.93 |
chr8_126774862_126775184 | 4.70 |
Gm45805 |
predicted gene 45805 |
16689 |
0.22 |
chr4_104824771_104824922 | 4.68 |
C8b |
complement component 8, beta polypeptide |
25638 |
0.17 |
chr12_99418877_99419035 | 4.67 |
Foxn3 |
forkhead box N3 |
6351 |
0.18 |
chr8_46404279_46404464 | 4.66 |
Gm45253 |
predicted gene 45253 |
18483 |
0.13 |
chr4_154024422_154024962 | 4.66 |
Smim1 |
small integral membrane protein 1 |
337 |
0.78 |
chr10_127879046_127879363 | 4.66 |
Rdh7 |
retinol dehydrogenase 7 |
9126 |
0.09 |
chr17_84895487_84895638 | 4.66 |
Gm49982 |
predicted gene, 49982 |
7007 |
0.18 |
chr18_70437586_70437747 | 4.65 |
Gm45879 |
predicted gene 45879 |
3810 |
0.22 |
chr7_111003851_111004038 | 4.64 |
Mrvi1 |
MRV integration site 1 |
21483 |
0.15 |
chr13_38089980_38090165 | 4.64 |
Gm27387 |
predicted gene, 27387 |
3870 |
0.2 |
chr7_97747129_97747413 | 4.64 |
Aqp11 |
aquaporin 11 |
8982 |
0.16 |
chr14_19170292_19170640 | 4.63 |
Gm8584 |
predicted gene 8584 |
10771 |
0.15 |
chr13_37715025_37715360 | 4.63 |
Gm40918 |
predicted gene, 40918 |
1119 |
0.39 |
chr6_144652995_144653148 | 4.62 |
Sox5it |
SRY (sex determining region Y)-box 5, intronic transcript |
19649 |
0.18 |
chr2_104130046_104130197 | 4.62 |
A930018P22Rik |
RIKEN cDNA A930018P22 gene |
7352 |
0.14 |
chr13_9057349_9057545 | 4.62 |
Gm36264 |
predicted gene, 36264 |
19004 |
0.13 |
chr3_121867514_121867696 | 4.61 |
Gm42593 |
predicted gene 42593 |
4763 |
0.19 |
chr18_34519910_34520170 | 4.60 |
n-R5s24 |
nuclear encoded rRNA 5S 24 |
10303 |
0.14 |
chr4_62384264_62384428 | 4.59 |
Slc31a1 |
solute carrier family 31, member 1 |
1155 |
0.38 |
chr8_18991275_18991446 | 4.57 |
Defb37 |
defensin beta 37 |
305 |
0.84 |
chr2_129214608_129214759 | 4.57 |
A730036I17Rik |
RIKEN cDNA A730036I17 gene |
4286 |
0.11 |
chr11_57671245_57671682 | 4.56 |
4933426K07Rik |
RIKEN cDNA 4933426K07 gene |
13637 |
0.15 |
chr11_11729316_11729485 | 4.54 |
Gm12000 |
predicted gene 12000 |
32961 |
0.14 |
chr2_4902415_4902737 | 4.54 |
Phyh |
phytanoyl-CoA hydroxylase |
16443 |
0.13 |
chr2_25485377_25485554 | 4.54 |
Lcn12 |
lipocalin 12 |
7967 |
0.07 |
chr1_154034260_154034430 | 4.53 |
Gm28286 |
predicted gene 28286 |
44 |
0.97 |
chr2_75705192_75705343 | 4.53 |
E030042O20Rik |
RIKEN cDNA E030042O20 gene |
497 |
0.49 |
chr17_88543781_88543932 | 4.53 |
Gm38109 |
predicted gene, 38109 |
10829 |
0.17 |
chr3_125270894_125271310 | 4.52 |
Gm42826 |
predicted gene 42826 |
51549 |
0.18 |
chr6_38929161_38929494 | 4.52 |
Tbxas1 |
thromboxane A synthase 1, platelet |
10303 |
0.2 |
chr5_23850355_23851323 | 4.52 |
2700038G22Rik |
RIKEN cDNA 2700038G22 gene |
238 |
0.81 |
chr15_80159254_80159657 | 4.51 |
Mgat3 |
mannoside acetylglucosaminyltransferase 3 |
14266 |
0.11 |
chr5_124605098_124605317 | 4.50 |
Tctn2 |
tectonic family member 2 |
6410 |
0.12 |
chr16_4470097_4470262 | 4.50 |
Adcy9 |
adenylate cyclase 9 |
49681 |
0.1 |
chr2_145232776_145233069 | 4.48 |
Slc24a3 |
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3 |
9689 |
0.28 |
chr9_43227749_43227955 | 4.48 |
Oaf |
out at first homolog |
2760 |
0.21 |
chr11_87749251_87749406 | 4.48 |
Mir142hg |
Mir142 host gene (non-protein coding) |
6249 |
0.09 |
chr7_100504925_100505084 | 4.47 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
6658 |
0.09 |
chr11_116620093_116620473 | 4.46 |
Rhbdf2 |
rhomboid 5 homolog 2 |
3917 |
0.12 |
chr12_111816703_111816903 | 4.45 |
Zfyve21 |
zinc finger, FYVE domain containing 21 |
547 |
0.64 |
chr9_85551941_85552115 | 4.43 |
Gm48834 |
predicted gene, 48834 |
1737 |
0.43 |
chr4_150221378_150221571 | 4.43 |
Gm13094 |
predicted gene 13094 |
6561 |
0.14 |
chr5_112001700_112002600 | 4.41 |
Gm42488 |
predicted gene 42488 |
57915 |
0.13 |
chr14_31433815_31434149 | 4.40 |
Sh3bp5 |
SH3-domain binding protein 5 (BTK-associated) |
2083 |
0.25 |
chr7_30358531_30358704 | 4.40 |
Gm25259 |
predicted gene, 25259 |
1693 |
0.15 |
chr13_59814696_59814883 | 4.40 |
Tut7 |
terminal uridylyl transferase 7 |
5283 |
0.11 |
chr5_105702692_105702912 | 4.39 |
Lrrc8d |
leucine rich repeat containing 8D |
1936 |
0.39 |
chr15_97380017_97380182 | 4.39 |
Pced1b |
PC-esterase domain containing 1B |
18882 |
0.24 |
chr5_27708254_27708552 | 4.37 |
Paxip1 |
PAX interacting (with transcription-activation domain) protein 1 |
42892 |
0.16 |
chr7_16046417_16047443 | 4.36 |
Bicra |
BRD4 interacting chromatin remodeling complex associated protein |
991 |
0.44 |
chr15_76690417_76690677 | 4.36 |
Ppp1r16a |
protein phosphatase 1, regulatory subunit 16A |
18 |
0.93 |
chr6_90621567_90621769 | 4.36 |
Slc41a3 |
solute carrier family 41, member 3 |
2521 |
0.21 |
chr7_110891747_110891926 | 4.35 |
Gm16336 |
predicted gene 16336 |
13149 |
0.15 |
chr4_116720426_116721428 | 4.34 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr13_3926117_3926428 | 4.33 |
Tubal3 |
tubulin, alpha-like 3 |
1577 |
0.26 |
chr3_127123331_127123826 | 4.33 |
Ank2 |
ankyrin 2, brain |
1284 |
0.39 |
chr11_79771332_79771811 | 4.32 |
9130204K15Rik |
RIKEN cDNA 9130204K15 gene |
11316 |
0.16 |
chr15_10959787_10959938 | 4.32 |
C1qtnf3 |
C1q and tumor necrosis factor related protein 3 |
7505 |
0.16 |
chr9_64814339_64814687 | 4.32 |
Dennd4a |
DENN/MADD domain containing 4A |
2969 |
0.28 |
chr13_37562665_37563032 | 4.30 |
Gm47751 |
predicted gene, 47751 |
2124 |
0.19 |
chr18_67699712_67699887 | 4.28 |
Ptpn2 |
protein tyrosine phosphatase, non-receptor type 2 |
9575 |
0.18 |
chr16_13205884_13206199 | 4.28 |
Mrtfb |
myocardin related transcription factor B |
50440 |
0.15 |
chr2_126575507_126575676 | 4.25 |
Slc27a2 |
solute carrier family 27 (fatty acid transporter), member 2 |
10831 |
0.18 |
chr14_17785456_17785612 | 4.24 |
Gm48320 |
predicted gene, 48320 |
14412 |
0.28 |
chr15_100436727_100436942 | 4.22 |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
11762 |
0.1 |
chr13_24419481_24419859 | 4.21 |
Cmah |
cytidine monophospho-N-acetylneuraminic acid hydroxylase |
2446 |
0.22 |
chr12_102691257_102691551 | 4.20 |
Itpk1 |
inositol 1,3,4-triphosphate 5/6 kinase |
4398 |
0.12 |
chr7_123430155_123430354 | 4.19 |
Lcmt1 |
leucine carboxyl methyltransferase 1 |
2394 |
0.29 |
chr19_40500083_40500248 | 4.18 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
12419 |
0.18 |
chr1_194679256_194679445 | 4.18 |
Gm38036 |
predicted gene, 38036 |
2348 |
0.25 |
chr11_61684240_61684947 | 4.17 |
Fam83g |
family with sequence similarity 83, member G |
174 |
0.94 |
chr1_119541086_119541484 | 4.16 |
3830432H09Rik |
RIKEN cDNA 3830432H09 gene |
5120 |
0.13 |
chr10_23800048_23800232 | 4.15 |
Slc18b1 |
solute carrier family 18, subfamily B, member 1 |
2940 |
0.16 |
chr3_96875239_96875430 | 4.14 |
Gpr89 |
G protein-coupled receptor 89 |
874 |
0.48 |
chr12_105757874_105758401 | 4.14 |
Ak7 |
adenylate kinase 7 |
12862 |
0.17 |
chr6_49047090_49047241 | 4.14 |
Gpnmb |
glycoprotein (transmembrane) nmb |
259 |
0.85 |
chr10_127205403_127205698 | 4.14 |
Pip4k2c |
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma |
6005 |
0.08 |
chr5_92292178_92292331 | 4.14 |
Gm43599 |
predicted gene 43599 |
2202 |
0.16 |
chr5_96919678_96919932 | 4.13 |
Gm8013 |
predicted gene 8013 |
1467 |
0.22 |
chr5_64579499_64580381 | 4.13 |
Gm42566 |
predicted gene 42566 |
15121 |
0.11 |
chr9_104161119_104161282 | 4.10 |
Dnajc13 |
DnaJ heat shock protein family (Hsp40) member C13 |
591 |
0.66 |
chr6_91193217_91193368 | 4.09 |
4930402H05Rik |
RIKEN cDNA 4930402H05 gene |
16752 |
0.12 |
chr12_110220612_110220914 | 4.09 |
Gm40576 |
predicted gene, 40576 |
15599 |
0.11 |
chr19_53329198_53330470 | 4.09 |
Mxi1 |
MAX interactor 1, dimerization protein |
26 |
0.97 |
chr6_34863371_34863577 | 4.09 |
Tmem140 |
transmembrane protein 140 |
212 |
0.89 |
chr14_27297109_27297304 | 4.08 |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
38860 |
0.15 |
chr11_115903493_115903793 | 4.08 |
Smim5 |
small integral membrane protein 5 |
3441 |
0.11 |
chr10_81092585_81092876 | 4.08 |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
155 |
0.88 |
chr13_36015731_36016008 | 4.07 |
Gm48770 |
predicted gene, 48770 |
20416 |
0.12 |
chr1_55173634_55173814 | 4.06 |
Gm6822 |
predicted pseudogene 6822 |
12671 |
0.12 |
chr2_174454161_174454337 | 4.05 |
Tubb1 |
tubulin, beta 1 class VI |
3554 |
0.14 |
chr10_94574788_94575101 | 4.05 |
Tmcc3 |
transmembrane and coiled coil domains 3 |
313 |
0.87 |
chr7_141276747_141276904 | 4.05 |
Cdhr5 |
cadherin-related family member 5 |
39 |
0.93 |
chr5_64710304_64710532 | 4.04 |
Gm20033 |
predicted gene, 20033 |
1470 |
0.35 |
chr11_35750522_35750899 | 4.04 |
Pank3 |
pantothenate kinase 3 |
18774 |
0.16 |
chr2_72785445_72785619 | 4.03 |
6430710C18Rik |
RIKEN cDNA 6430710C18 gene |
14622 |
0.23 |
chr2_51137657_51137866 | 4.03 |
Rnd3 |
Rho family GTPase 3 |
11333 |
0.25 |
chr2_158305932_158306715 | 4.03 |
Lbp |
lipopolysaccharide binding protein |
170 |
0.92 |
chr11_48873308_48874023 | 4.02 |
Irgm1 |
immunity-related GTPase family M member 1 |
1982 |
0.19 |
chr2_148045489_148046522 | 4.02 |
Foxa2 |
forkhead box A2 |
57 |
0.97 |
chr10_75565842_75566317 | 4.01 |
Ggt1 |
gamma-glutamyltransferase 1 |
214 |
0.88 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.6 | 10.4 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
2.3 | 7.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.1 | 6.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
2.1 | 6.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
2.0 | 2.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.9 | 11.6 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
1.9 | 5.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.8 | 1.8 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
1.7 | 5.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.7 | 5.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
1.7 | 5.1 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
1.7 | 5.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
1.6 | 8.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
1.6 | 8.1 | GO:0006116 | NADH oxidation(GO:0006116) |
1.6 | 8.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.6 | 3.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
1.6 | 4.8 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
1.6 | 4.7 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.6 | 4.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.5 | 4.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
1.5 | 4.5 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.5 | 4.4 | GO:1902896 | terminal web assembly(GO:1902896) |
1.5 | 7.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.5 | 4.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 5.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.4 | 7.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
1.4 | 4.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.4 | 2.9 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
1.4 | 5.7 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.4 | 4.2 | GO:0008050 | female courtship behavior(GO:0008050) |
1.4 | 4.1 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.4 | 6.9 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.4 | 4.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.3 | 5.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.3 | 6.7 | GO:1904970 | brush border assembly(GO:1904970) |
1.3 | 4.0 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.3 | 3.8 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
1.3 | 3.8 | GO:0061626 | pharyngeal arch artery morphogenesis(GO:0061626) |
1.3 | 7.6 | GO:0001705 | ectoderm formation(GO:0001705) |
1.3 | 3.8 | GO:0032439 | endosome localization(GO:0032439) |
1.3 | 5.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.3 | 10.0 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
1.2 | 4.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
1.2 | 3.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.2 | 3.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.2 | 3.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
1.2 | 7.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.1 | 3.4 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.1 | 4.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 4.5 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
1.1 | 3.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
1.1 | 5.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
1.1 | 6.6 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.1 | 3.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
1.1 | 6.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.1 | 1.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 3.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
1.1 | 7.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
1.0 | 5.2 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.0 | 8.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.0 | 4.2 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.0 | 3.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.0 | 3.1 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
1.0 | 4.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
1.0 | 3.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
1.0 | 5.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
1.0 | 4.0 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.0 | 3.0 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
1.0 | 3.9 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.0 | 3.9 | GO:0019532 | oxalate transport(GO:0019532) |
1.0 | 4.9 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.0 | 5.9 | GO:0050957 | equilibrioception(GO:0050957) |
1.0 | 1.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.0 | 1.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.9 | 2.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.9 | 4.7 | GO:0042737 | drug catabolic process(GO:0042737) |
0.9 | 3.7 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
0.9 | 2.7 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.9 | 5.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.9 | 1.8 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.9 | 2.6 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
0.9 | 2.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.9 | 5.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.9 | 2.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.9 | 2.6 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.9 | 2.6 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.9 | 8.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.9 | 2.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.8 | 2.5 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.8 | 2.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.8 | 2.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.8 | 1.7 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.8 | 4.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.8 | 2.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.8 | 4.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.8 | 2.4 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 2.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.8 | 3.2 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.8 | 2.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 1.6 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.8 | 2.3 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.8 | 2.3 | GO:0010989 | negative regulation of lipoprotein particle clearance(GO:0010985) negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.8 | 2.3 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.8 | 0.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.8 | 2.3 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.8 | 2.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.7 | 5.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.7 | 2.2 | GO:0032782 | bile acid secretion(GO:0032782) |
0.7 | 3.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.7 | 2.2 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.7 | 3.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.7 | 2.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.7 | 2.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 3.6 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.7 | 0.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.7 | 3.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.7 | 2.1 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.7 | 5.6 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.7 | 4.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.7 | 1.4 | GO:0045472 | response to ether(GO:0045472) |
0.7 | 0.7 | GO:0043366 | beta selection(GO:0043366) |
0.7 | 4.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 1.4 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.7 | 2.8 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 10.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 6.8 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.7 | 2.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.7 | 3.4 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.7 | 3.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.7 | 2.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.7 | 4.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 1.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.7 | 2.0 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.7 | 2.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.7 | 2.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.6 | 5.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.6 | 2.6 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.6 | 5.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 0.6 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.6 | 2.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.6 | 1.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.6 | 1.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.6 | 1.9 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.6 | 4.9 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.6 | 3.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 1.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 3.7 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.6 | 1.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.6 | 3.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.6 | 1.8 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.6 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.6 | 1.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.6 | 0.6 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.6 | 1.2 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
0.6 | 1.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.6 | 3.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 2.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.6 | 1.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.6 | 1.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.6 | 1.7 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 3.4 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 1.1 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.6 | 1.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.6 | 1.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.6 | 1.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.5 | 6.0 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 2.7 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.5 | 0.5 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.5 | 4.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 2.2 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.5 | 1.6 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 2.7 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.5 | 2.2 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.5 | 2.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 1.6 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 1.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
0.5 | 0.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.5 | 2.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.5 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 1.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 2.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 3.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.5 | 3.2 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.5 | 3.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 3.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.5 | 2.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 3.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.5 | 0.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.5 | 1.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 1.6 | GO:0061511 | centriole elongation(GO:0061511) |
0.5 | 1.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.5 | 1.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.5 | 1.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.5 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.5 | 1.0 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 2.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.5 | 1.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.5 | 1.5 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.5 | 2.0 | GO:0000050 | urea cycle(GO:0000050) |
0.5 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.5 | 2.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.5 | 1.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.5 | 1.5 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.5 | 1.0 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 1.0 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 3.0 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.5 | 1.0 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
0.5 | 4.4 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.5 | 4.9 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.5 | 1.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.5 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 0.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.5 | 0.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.5 | 3.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.5 | 1.9 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.5 | 3.4 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.5 | 1.4 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.5 | 0.5 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.5 | 7.2 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.5 | 1.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.5 | 1.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.5 | 1.9 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 0.9 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.5 | 1.9 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.5 | 6.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.5 | 1.4 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.5 | 0.9 | GO:0009597 | detection of virus(GO:0009597) |
0.5 | 0.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.5 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 3.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.5 | 0.9 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.5 | 0.9 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.5 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.5 | 3.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 1.4 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.5 | 5.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.5 | 1.4 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.5 | 0.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 5.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.5 | 2.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.5 | 0.9 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.5 | 2.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.5 | 1.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.5 | 1.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 1.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.5 | 1.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.5 | 4.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 0.9 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
0.4 | 0.9 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.4 | 1.8 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.4 | 4.9 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.4 | 3.1 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 0.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 4.0 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 1.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.4 | 0.9 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.4 | 0.9 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 1.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.4 | 0.9 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.4 | 3.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 0.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 9.3 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 0.4 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.4 | 3.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.4 | 1.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.4 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 0.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.4 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 2.1 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.4 | 0.4 | GO:0097459 | iron ion import into cell(GO:0097459) |
0.4 | 2.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 1.2 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.4 | 2.9 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.4 | 0.4 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 0.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 1.2 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 0.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.4 | 1.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.4 | 2.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 1.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.4 | 1.6 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.4 | 0.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 1.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 0.8 | GO:0006848 | pyruvate transport(GO:0006848) |
0.4 | 1.2 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 0.8 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 1.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.4 | 3.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 7.9 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.4 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 2.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 0.8 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 0.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.4 | 0.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.4 | 1.6 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.4 | 1.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.4 | 3.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.4 | 1.2 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.4 | 1.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 0.8 | GO:0010159 | specification of organ position(GO:0010159) |
0.4 | 1.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 0.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 2.7 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.4 | 0.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.4 | 2.3 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 6.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 1.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.4 | 0.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 0.4 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.4 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.4 | 3.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 1.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 1.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 2.3 | GO:0001768 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.4 | 1.5 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.4 | 9.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.4 | 0.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.4 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 0.4 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
0.4 | 1.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.4 | 1.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.4 | 1.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 4.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 0.4 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.4 | 1.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.4 | 0.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 1.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.4 | 0.4 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.4 | 1.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.4 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.4 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.4 | 0.4 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.4 | 0.7 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.4 | 2.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.4 | 1.4 | GO:0042546 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.4 | 2.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.4 | 3.6 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.4 | 1.1 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.4 | 1.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 3.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 1.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.4 | 1.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 1.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 0.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
0.4 | 1.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 1.1 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.4 | 2.1 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 0.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.3 | 1.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 1.4 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.3 | 1.0 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.3 | 0.7 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.3 | 1.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 1.0 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.3 | 0.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.3 | 1.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.3 | 0.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.3 | 1.0 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.3 | 1.4 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.3 | 0.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.3 | 1.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 1.0 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 1.0 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.3 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.0 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.3 | 0.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.3 | 7.1 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.3 | 1.0 | GO:0008228 | opsonization(GO:0008228) |
0.3 | 0.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.3 | 2.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 2.7 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
0.3 | 1.3 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.3 | 1.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.3 | 1.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.3 | 0.7 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) regulation of receptor localization to synapse(GO:1902683) |
0.3 | 0.3 | GO:0033092 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
0.3 | 1.7 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.3 | 1.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.3 | 3.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.3 | 0.7 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 3.6 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.3 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 5.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.3 | 4.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.3 | 1.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 9.0 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 1.0 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.3 | 2.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 1.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.3 | 1.9 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.3 | 1.9 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.3 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.3 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.6 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 4.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.3 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.3 | 1.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.3 | 2.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 4.9 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.3 | 0.9 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 0.6 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.3 | 1.8 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 0.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.3 | 0.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.3 | 3.4 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 0.9 | GO:0051610 | serotonin uptake(GO:0051610) |
0.3 | 0.9 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.3 | 3.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.3 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 0.9 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.3 | 0.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.3 | 1.8 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.3 | 0.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 1.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.3 | 0.6 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 0.6 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.3 | 0.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.3 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.3 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.3 | 1.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.3 | 0.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 0.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.3 | 0.6 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.3 | 0.3 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.3 | 0.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.2 | GO:0031659 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.3 | 1.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.3 | 1.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.3 | 1.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 0.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.3 | 2.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 0.9 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.3 | 0.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 0.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 0.3 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.3 | 1.7 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.3 | 2.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 1.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 0.3 | GO:0072603 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) regulation of interleukin-13 secretion(GO:2000665) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 1.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 2.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 2.8 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 0.8 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.8 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 0.6 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 0.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 0.8 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 0.6 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.9 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.3 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.3 | 2.2 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 1.6 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.3 | 0.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 1.6 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) |
0.3 | 1.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.3 | 0.8 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 0.8 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.3 | 1.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 0.5 | GO:1903416 | response to glycoside(GO:1903416) |
0.3 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.1 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.3 | 0.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.3 | 0.5 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.3 | 0.8 | GO:0002838 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.3 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 1.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.3 | 1.3 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 1.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 1.3 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.3 | 0.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 5.0 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.3 | 2.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.3 | 0.8 | GO:0097286 | iron ion import(GO:0097286) |
0.3 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 3.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.3 | 2.6 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.3 | 1.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.3 | 1.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 1.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 0.5 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of RNA export from nucleus(GO:0046831) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.3 | 1.0 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.3 | 1.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.3 | 0.5 | GO:1902402 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.3 | 2.8 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.8 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.3 | 1.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.3 | 1.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.3 | 2.0 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.2 | 1.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.2 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.2 | 0.5 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 3.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 2.2 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 1.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 2.0 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.5 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.5 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 1.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.2 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.2 | 1.0 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 1.7 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 0.2 | GO:0002673 | regulation of acute inflammatory response(GO:0002673) |
0.2 | 0.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.2 | 1.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.2 | 0.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 0.2 | GO:1903596 | regulation of gap junction assembly(GO:1903596) positive regulation of gap junction assembly(GO:1903598) |
0.2 | 1.7 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 0.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 0.2 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.2 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) |
0.2 | 1.4 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 5.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 0.7 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 4.0 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.2 | 1.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.9 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.2 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.2 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 0.5 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 0.2 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.7 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.2 | 1.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.2 | 0.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 0.5 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 1.2 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.9 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.2 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.2 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 3.4 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 0.9 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.2 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 2.7 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.2 | 1.6 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.2 | 0.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.2 | 0.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.2 | 0.5 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 2.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.2 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.2 | 2.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
0.2 | 1.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 3.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.2 | 1.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.2 | 0.2 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.2 | 1.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.2 | 0.7 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.2 | 0.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.2 | 3.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.2 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.2 | 1.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.2 | 0.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 0.4 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
0.2 | 4.1 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.2 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 6.2 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.2 | 1.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.2 | 0.6 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.2 | 0.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.2 | 0.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 1.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.2 | 8.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.2 | 0.8 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.2 | 1.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 1.1 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.2 | 1.1 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.2 | 1.7 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.2 | 1.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.2 | 1.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.2 | 3.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.2 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.4 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.6 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.2 | 0.6 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 0.6 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.2 | 0.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.2 | 2.9 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.2 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.2 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 4.5 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.2 | 0.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.2 | 0.6 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 1.0 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.4 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.2 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 1.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 2.0 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.2 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.2 | 1.6 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.2 | 0.4 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.2 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 1.6 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 0.4 | GO:0051383 | kinetochore organization(GO:0051383) |
0.2 | 0.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.2 | 0.6 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 1.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.2 | 1.1 | GO:0051905 | establishment of pigment granule localization(GO:0051905) |
0.2 | 1.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 1.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 1.7 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.2 | 0.4 | GO:0048617 | embryonic foregut morphogenesis(GO:0048617) |
0.2 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 4.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.2 | 0.2 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.2 | 0.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 2.2 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.6 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.2 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.4 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
0.2 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.2 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.6 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 0.9 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.4 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.2 | 0.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.4 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.2 | 8.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.2 | 0.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.2 | 0.9 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 4.7 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 2.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.4 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 1.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.2 | 0.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.5 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.2 | 0.9 | GO:0002441 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.2 | 1.1 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.2 | 0.4 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 1.2 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.2 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.2 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.3 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 1.0 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.2 | 2.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.3 | GO:0034311 | diol metabolic process(GO:0034311) |
0.2 | 4.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 4.0 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.2 | 0.3 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.2 | 0.3 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.2 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.3 | GO:1903897 | regulation of PERK-mediated unfolded protein response(GO:1903897) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.2 | 0.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.7 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) positive regulation of protein polyubiquitination(GO:1902916) |
0.2 | 1.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 | 0.3 | GO:0051875 | pigment granule localization(GO:0051875) |
0.2 | 1.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.2 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.5 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 2.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 1.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
0.2 | 2.4 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.2 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.2 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.2 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.2 | 0.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.2 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 1.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.2 | 0.2 | GO:2001140 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.2 | 1.3 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.2 | 0.8 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.2 | 0.7 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.2 | 1.3 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.2 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.2 | 0.5 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.2 | 0.7 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 1.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 1.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.2 | 1.8 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.2 | 1.5 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 1.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.2 | 0.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 1.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.2 | 1.8 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.2 | 0.8 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 0.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.2 | 1.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.2 | 0.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.8 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 0.5 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.2 | 0.2 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.9 | GO:0097421 | liver regeneration(GO:0097421) |
0.2 | 0.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 0.9 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.2 | 0.3 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
0.2 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 7.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.2 | 0.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.2 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.9 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.2 | 0.2 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.2 | 0.5 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.2 | 0.5 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.2 | 0.6 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.2 | 0.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.1 | 1.0 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 1.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 1.0 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.1 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.6 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 1.0 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 1.4 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 1.1 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.1 | 0.1 | GO:2000978 | negative regulation of forebrain neuron differentiation(GO:2000978) |
0.1 | 0.9 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 2.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.8 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.1 | 1.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.1 | 0.1 | GO:0045628 | regulation of T-helper 2 cell differentiation(GO:0045628) |
0.1 | 1.3 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.6 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.1 | 0.3 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.7 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 3.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.1 | 0.4 | GO:0001555 | oocyte growth(GO:0001555) |
0.1 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.1 | 0.1 | GO:0019585 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
0.1 | 5.4 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.6 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.7 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.1 | 0.3 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 1.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 7.5 | GO:1901568 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.1 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.4 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.1 | 1.7 | GO:0043489 | RNA stabilization(GO:0043489) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 1.1 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 4.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 1.3 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.1 | 0.8 | GO:0010388 | cullin deneddylation(GO:0010388) |
0.1 | 0.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.1 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.4 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:1902117 | positive regulation of organelle assembly(GO:1902117) |
0.1 | 0.4 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.1 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.5 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.1 | 0.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 1.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.4 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
0.1 | 0.4 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.2 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 3.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.1 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.4 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.1 | GO:0008216 | spermidine metabolic process(GO:0008216) |
0.1 | 0.5 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 1.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.1 | 0.2 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.5 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 1.2 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.2 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
0.1 | 0.1 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.8 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.4 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.1 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) |
0.1 | 0.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.8 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.1 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 1.3 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.1 | 2.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 0.1 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.2 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.2 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.1 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 0.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.3 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 3.0 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.3 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.1 | 0.1 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 2.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.3 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.7 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.5 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.1 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.5 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 1.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.2 | GO:0003097 | renal water transport(GO:0003097) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.1 | 0.1 | GO:0033026 | negative regulation of mast cell apoptotic process(GO:0033026) |
0.1 | 0.1 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 1.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.3 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.1 | 0.5 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 0.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 3.0 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.4 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.1 | 0.5 | GO:0060068 | vagina development(GO:0060068) |
0.1 | 0.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.1 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.4 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.2 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 0.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 2.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.1 | 0.7 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.1 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) |
0.1 | 0.6 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.3 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.4 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.1 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.1 | 0.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.2 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.1 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 1.1 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.7 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.5 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.7 | GO:0070266 | necroptotic process(GO:0070266) |
0.1 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 1.7 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0006971 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.1 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.4 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.1 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.2 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.1 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.2 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.1 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 0.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.1 | 0.2 | GO:0032048 | cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.1 | 0.1 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.7 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.1 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.1 | 0.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0043584 | nose development(GO:0043584) |
0.1 | 2.0 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.1 | GO:0021569 | rhombomere 3 development(GO:0021569) rhombomere 4 development(GO:0021570) |
0.1 | 0.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.2 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.1 | 0.2 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.7 | GO:0002251 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.1 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.7 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.9 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.5 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.2 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.5 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.3 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.7 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.1 | 0.4 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.5 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.1 | 0.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 1.4 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.3 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 1.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.1 | 2.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.9 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.3 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.1 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:2000319 | regulation of T-helper 17 cell differentiation(GO:2000319) |
0.1 | 0.1 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 1.3 | GO:0006638 | neutral lipid metabolic process(GO:0006638) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.1 | 0.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.1 | 0.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.1 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.1 | 0.1 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.1 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) |
0.1 | 0.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.6 | GO:0050891 | multicellular organismal water homeostasis(GO:0050891) |
0.1 | 0.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.5 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.1 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.8 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.5 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 0.6 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.7 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.1 | 0.1 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.1 | 0.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 1.9 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.1 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 0.6 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.1 | 0.2 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.1 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.1 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.1 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 0.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.4 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 0.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.4 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.1 | 0.1 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 0.2 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.7 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 0.1 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.3 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.1 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.1 | 0.2 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.1 | 0.1 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.6 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 1.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 1.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0051132 | NK T cell activation(GO:0051132) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 1.0 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.0 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.0 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 1.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 1.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.0 | 2.2 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.0 | GO:0071599 | otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.5 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 7.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.2 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.0 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.0 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.0 | 0.0 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.2 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.0 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0045144 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.2 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.0 | 0.0 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.0 | 0.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.1 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.8 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.0 | 1.0 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 0.1 | GO:0046006 | regulation of activated T cell proliferation(GO:0046006) |
0.0 | 0.0 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.5 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.0 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.1 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.3 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.7 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0023058 | adaptation of signaling pathway(GO:0023058) |
0.0 | 0.0 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.0 | 0.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.0 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.0 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
0.0 | 0.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.2 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.1 | GO:0009299 | mRNA transcription(GO:0009299) |
0.0 | 0.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.0 | 0.0 | GO:0045023 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) positive regulation of G0 to G1 transition(GO:0070318) |
0.0 | 0.1 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.0 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.1 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.0 | 0.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.1 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.0 | 0.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.0 | 0.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.2 | GO:0032965 | regulation of collagen biosynthetic process(GO:0032965) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.0 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.0 | 0.0 | GO:0046070 | dGTP metabolic process(GO:0046070) purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 0.0 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.0 | 0.2 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.0 | 0.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.0 | 0.0 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.0 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0002716 | negative regulation of natural killer cell mediated immunity(GO:0002716) |
0.0 | 0.0 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.0 | 2.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.0 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.0 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.0 | 0.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.0 | 0.0 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.6 | GO:0006956 | complement activation(GO:0006956) |
0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.0 | 0.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.0 | GO:0071285 | response to lithium ion(GO:0010226) cellular response to lithium ion(GO:0071285) |
0.0 | 0.0 | GO:0009642 | response to light intensity(GO:0009642) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.0 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.0 | 0.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.0 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.0 | 0.0 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.1 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.0 | 0.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.0 | 0.0 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.0 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.0 | 0.0 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.0 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.0 | 0.0 | GO:0034508 | centromere complex assembly(GO:0034508) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.3 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
1.3 | 4.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.3 | 6.6 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.3 | 1.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.2 | 6.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.2 | 5.9 | GO:0031094 | platelet dense tubular network(GO:0031094) |
1.2 | 3.5 | GO:0031523 | Myb complex(GO:0031523) |
1.1 | 17.1 | GO:0031528 | microvillus membrane(GO:0031528) |
1.1 | 2.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.1 | 5.6 | GO:0031983 | vesicle lumen(GO:0031983) |
1.1 | 3.2 | GO:0097413 | Lewy body(GO:0097413) |
0.9 | 3.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.9 | 7.1 | GO:0045179 | apical cortex(GO:0045179) |
0.9 | 4.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.8 | 3.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.8 | 4.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.8 | 3.2 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 3.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.8 | 2.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 3.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.7 | 3.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 6.6 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.7 | 2.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.7 | 2.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.6 | 1.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 1.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 3.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.6 | 4.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 1.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.6 | 2.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 4.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 2.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.6 | 2.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.6 | 1.7 | GO:1990923 | PET complex(GO:1990923) |
0.5 | 2.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 0.5 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.5 | 2.7 | GO:0005638 | lamin filament(GO:0005638) |
0.5 | 1.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.5 | 1.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 4.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 1.6 | GO:1990357 | terminal web(GO:1990357) |
0.5 | 2.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 3.1 | GO:0031415 | NatA complex(GO:0031415) |
0.5 | 1.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.5 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.5 | 1.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.5 | 2.9 | GO:0097542 | ciliary tip(GO:0097542) |
0.5 | 1.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 1.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.5 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 1.4 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.5 | 0.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 1.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.4 | 1.8 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.4 | 1.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.4 | 1.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 1.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.4 | 1.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 4.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 2.9 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 0.4 | GO:1903349 | omegasome membrane(GO:1903349) |
0.4 | 2.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 0.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.4 | 2.0 | GO:0061617 | MICOS complex(GO:0061617) |
0.4 | 1.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 2.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.4 | 1.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.4 | 1.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.4 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.4 | 2.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 0.7 | GO:0044327 | dendritic spine head(GO:0044327) |
0.4 | 7.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.4 | 2.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.4 | 1.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 1.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 7.5 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 5.5 | GO:0000145 | exocyst(GO:0000145) |
0.3 | 9.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.7 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.0 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.3 | 0.6 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 1.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.3 | 1.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.3 | 1.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 0.9 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.3 | 1.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 2.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 1.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 1.2 | GO:0032584 | growth cone membrane(GO:0032584) |
0.3 | 3.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.3 | 3.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 0.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 1.2 | GO:0000805 | X chromosome(GO:0000805) |
0.3 | 1.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.3 | 12.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 0.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 2.9 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 0.3 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 0.8 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 0.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 6.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.3 | 5.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 1.1 | GO:0071203 | WASH complex(GO:0071203) |
0.3 | 1.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.3 | 3.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 1.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 1.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 4.1 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.3 | 1.1 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.1 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.3 | 3.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 26.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 5.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.3 | 2.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 0.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.3 | 5.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 3.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 2.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 2.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 1.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.0 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 0.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 13.4 | GO:0031526 | brush border membrane(GO:0031526) |
0.2 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.4 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.9 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 0.9 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 0.7 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 2.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 5.9 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 3.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 5.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 11.9 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 1.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 2.9 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 0.7 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 2.6 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 1.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 2.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.2 | 11.5 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 9.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 2.6 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 2.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 0.6 | GO:0005712 | chiasma(GO:0005712) |
0.2 | 1.5 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.2 | 1.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 6.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 2.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 1.0 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.2 | 1.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.2 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 0.6 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 1.6 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 1.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 3.9 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.2 | 0.8 | GO:0000792 | heterochromatin(GO:0000792) |
0.2 | 1.2 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 0.6 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.2 | 24.6 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 1.9 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.2 | 0.2 | GO:0044393 | microspike(GO:0044393) |
0.2 | 6.2 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 3.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.9 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 0.7 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 2.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 0.7 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 1.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 1.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.5 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.2 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.2 | 0.3 | GO:1990777 | plasma lipoprotein particle(GO:0034358) low-density lipoprotein particle(GO:0034362) lipoprotein particle(GO:1990777) |
0.2 | 1.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.2 | 1.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.2 | 3.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.2 | 1.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.0 | GO:0042581 | specific granule(GO:0042581) |
0.2 | 0.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.8 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 7.3 | GO:0016605 | PML body(GO:0016605) |
0.2 | 2.3 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.2 | 4.4 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 1.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 1.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.6 | GO:0042825 | TAP complex(GO:0042825) |
0.2 | 1.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 1.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 1.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 6.4 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 1.6 | GO:0005657 | replication fork(GO:0005657) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 8.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.1 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 8.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 2.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.9 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 1.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 1.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 1.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.0 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 1.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 1.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.4 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.3 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.1 | 1.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 0.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.7 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 10.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 9.7 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 2.3 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 3.1 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 1.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.5 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 2.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.1 | 4.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 1.2 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 4.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 4.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 3.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 0.5 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 2.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 4.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 1.6 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 5.8 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 23.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 2.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.5 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 1.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 3.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 34.2 | GO:0005730 | nucleolus(GO:0005730) |
0.1 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 3.5 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 6.3 | GO:0005819 | spindle(GO:0005819) |
0.1 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 3.2 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 2.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.1 | 1.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.2 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.1 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.2 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 1.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 1.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 45.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.5 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.9 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.7 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.0 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 28.6 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.3 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 2.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 6.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 39.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 2.9 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.7 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.0 | GO:0042585 | germinal vesicle(GO:0042585) |
0.0 | 0.8 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.0 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.0 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.0 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.1 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 7.0 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 7.8 | GO:0005739 | mitochondrion(GO:0005739) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 11.9 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
1.7 | 8.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.6 | 6.5 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.4 | 4.3 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.4 | 7.1 | GO:0070061 | fructose binding(GO:0070061) |
1.4 | 7.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.4 | 4.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.3 | 3.9 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.2 | 6.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.2 | 3.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.1 | 3.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.1 | 4.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.1 | 4.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.1 | 3.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
1.1 | 4.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.1 | 3.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.0 | 3.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 3.9 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.0 | 3.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.9 | 0.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.9 | 2.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.9 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.9 | 3.6 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.9 | 3.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 5.4 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.9 | 13.2 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.9 | 7.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.9 | 2.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.9 | 7.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.9 | 6.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.8 | 5.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.8 | 2.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.8 | 2.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 2.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.8 | 3.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 1.6 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.8 | 2.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.8 | 3.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.8 | 7.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 2.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.8 | 2.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.8 | 3.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.8 | 7.8 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.8 | 1.5 | GO:0008430 | selenium binding(GO:0008430) |
0.8 | 6.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 3.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 3.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.7 | 2.2 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.7 | 3.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.7 | 2.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.7 | 2.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 5.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.7 | 4.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.7 | 6.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.7 | 2.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.7 | 2.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.7 | 0.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.7 | 2.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.7 | 2.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.7 | 2.0 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.6 | 1.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.6 | 2.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.6 | 3.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.6 | 3.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 1.9 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.6 | 2.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.6 | 9.7 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.6 | 3.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.6 | 1.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 9.6 | GO:0035173 | histone kinase activity(GO:0035173) |
0.6 | 1.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 13.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 2.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.6 | 4.1 | GO:0005113 | patched binding(GO:0005113) |
0.6 | 1.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 1.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.6 | 2.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.6 | 2.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 1.1 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 3.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.6 | 1.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.6 | 1.7 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.6 | 2.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.5 | 9.3 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.5 | 1.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.5 | 2.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 1.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.5 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.5 | 0.5 | GO:0008425 | C-methyltransferase activity(GO:0008169) 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity(GO:0008425) quinone cofactor methyltransferase activity(GO:0030580) |
0.5 | 3.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
0.5 | 3.8 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 6.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.5 | 1.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 2.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 5.2 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.5 | 3.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.5 | 1.6 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.5 | 2.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.5 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 2.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.5 | 2.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 7.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 3.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.5 | 2.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 2.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.5 | 1.5 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.5 | 4.0 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.5 | 1.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 7.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 1.5 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.5 | 1.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 2.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.5 | 1.9 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.5 | 1.4 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.5 | 4.3 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.5 | 2.8 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.5 | 0.9 | GO:0052745 | inositol bisphosphate phosphatase activity(GO:0016312) inositol phosphate phosphatase activity(GO:0052745) |
0.5 | 13.2 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.5 | 6.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 0.9 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.5 | 3.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.5 | 3.7 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 2.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 0.5 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
0.5 | 1.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 2.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 1.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 1.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 4.0 | GO:0001846 | opsonin binding(GO:0001846) |
0.4 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
0.4 | 0.9 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.4 | 1.8 | GO:0043515 | kinetochore binding(GO:0043515) |
0.4 | 1.3 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 7.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 1.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.4 | 2.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.4 | 1.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.4 | 1.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.4 | 3.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.4 | 6.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 6.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 3.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 4.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 8.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 1.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.4 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 0.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.4 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 0.8 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.4 | 1.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.4 | 0.4 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 1.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.4 | 2.8 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.4 | 4.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.4 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.4 | 2.3 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.4 | 1.9 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 1.2 | GO:0001226 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.4 | 3.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 1.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 1.5 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.4 | 1.9 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.4 | 1.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.4 | 1.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.4 | 1.1 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.4 | 1.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.4 | 6.3 | GO:0071949 | FAD binding(GO:0071949) |
0.4 | 0.7 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.4 | 2.6 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.4 | 2.6 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.4 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 1.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.4 | 0.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.4 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 1.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.3 | 2.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.3 | 0.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.3 | 1.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.3 | 2.0 | GO:0034891 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.3 | 1.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.3 | 0.7 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.3 | 1.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 3.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 8.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 1.0 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 0.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.3 | 3.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 1.3 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.3 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 4.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 2.2 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.3 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.3 | 10.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.3 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.3 | 5.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.3 | 1.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.5 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.3 | 1.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 5.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.3 | 0.9 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.3 | 0.9 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.3 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 5.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 0.9 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 1.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 3.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.3 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 6.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.3 | 2.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 3.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 8.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.3 | 1.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.3 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 3.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.3 | 0.8 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 0.3 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.3 | 1.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 0.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 1.3 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 1.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.3 | 2.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 7.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.3 | 2.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.3 | 2.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 1.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.3 | 1.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 0.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.3 | 0.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.5 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 3.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.3 | 0.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 0.8 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.3 | 0.8 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 3.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.8 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.3 | 1.0 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.3 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.3 | 1.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.3 | 1.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 2.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 1.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 5.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 3.0 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
0.2 | 2.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 7.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.2 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 1.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 2.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.2 | 1.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.2 | 0.2 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 0.9 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.2 | 1.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 3.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 0.9 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 0.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 2.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 1.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.2 | 0.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 2.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 4.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 1.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 2.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 4.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 1.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.7 | GO:0019002 | GMP binding(GO:0019002) |
0.2 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 3.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.2 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.1 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.9 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 3.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 5.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.6 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 5.5 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 3.8 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 2.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 1.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.2 | 0.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.2 | 2.9 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.2 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.2 | 1.0 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 3.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 8.0 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.2 | 1.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.2 | 3.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 1.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 1.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 3.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.2 | 0.6 | GO:0016531 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 0.8 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.2 | 1.4 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 3.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.2 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.2 | 1.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.2 | 4.4 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.4 | GO:0018653 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 3.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 0.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 5.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.2 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 0.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 1.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 1.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.4 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 2.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 1.9 | GO:0016918 | retinal binding(GO:0016918) |
0.2 | 19.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 4.2 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.2 | 0.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.5 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 1.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 0.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 1.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 0.5 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.2 | 0.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 0.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.2 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 1.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.2 | 0.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.2 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 2.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 0.5 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.2 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.2 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.1 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.2 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 0.5 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 1.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 1.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 0.5 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.2 | 7.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 7.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.2 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 1.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.5 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 2.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 2.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 1.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 1.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.6 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 15.1 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.1 | 10.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.6 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 14.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 0.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.3 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 3.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 19.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.8 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 2.8 | GO:0043914 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.7 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 2.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 1.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 1.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 1.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 1.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.0 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 1.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.4 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.1 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.8 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.2 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 3.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 2.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 1.2 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 1.0 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.1 | 1.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.9 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.7 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.6 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 2.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.2 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.3 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 0.8 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.4 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 2.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 4.4 | GO:0020037 | heme binding(GO:0020037) tetrapyrrole binding(GO:0046906) |
0.1 | 0.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 3.1 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 4.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.1 | 9.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.3 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 2.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 0.6 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 0.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.8 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 2.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0016209 | antioxidant activity(GO:0016209) |
0.1 | 0.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 3.4 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.3 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 2.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 0.8 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.1 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.1 | 0.7 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.1 | 2.0 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 1.6 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
0.1 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.5 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.8 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 3.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.1 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.1 | 2.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.3 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 2.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.1 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.4 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 2.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.4 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 2.7 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.1 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.3 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.1 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 0.1 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.1 | 0.2 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 0.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.1 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.1 | 0.1 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.1 | 0.1 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 1.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.1 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.4 | GO:0005222 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) intracellular cAMP activated cation channel activity(GO:0005222) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.1 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.0 | 1.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.0 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.4 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.1 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 1.3 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.0 | 0.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.5 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 7.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 5.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.8 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.4 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.0 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.0 | 2.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.0 | 0.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 1.8 | GO:0051020 | GTPase binding(GO:0051020) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 0.0 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.0 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.0 | 0.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.0 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 0.2 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.1 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 44.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.8 | 12.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.7 | 5.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.6 | 5.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 0.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.5 | 4.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 20.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 2.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 6.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 11.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 7.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 10.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.4 | 15.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.4 | 14.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 12.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 1.5 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 3.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 3.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 6.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 1.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 1.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 7.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 17.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 6.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 11.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 0.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 11.2 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.3 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 3.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 3.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 5.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 5.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 8.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 3.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.3 | 1.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 3.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.2 | 8.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 4.2 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 1.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 7.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 0.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 1.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 1.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 10.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 3.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 1.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 3.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.6 | PID ATM PATHWAY | ATM pathway |
0.2 | 5.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.2 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 0.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 2.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 0.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 1.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 1.5 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 0.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 2.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 2.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.6 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 7.7 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 2.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.8 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 2.5 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 1.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 1.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.8 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.0 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 2.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 12.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.1 | 3.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.1 | 9.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.9 | 11.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 0.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.8 | 10.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.8 | 7.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.7 | 11.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.7 | 0.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.7 | 5.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.6 | 11.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.6 | 0.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 6.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.6 | 18.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.6 | 1.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.6 | 4.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.6 | 5.9 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 8.8 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.6 | 5.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 5.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.6 | 6.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.6 | 10.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.6 | 14.4 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.6 | 12.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.5 | 4.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 3.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.5 | 14.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.5 | 3.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 5.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 1.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.5 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 2.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.4 | 12.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 11.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.4 | 1.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.4 | 6.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 3.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 4.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.4 | 7.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.4 | 2.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.4 | 4.1 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 2.0 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.4 | 0.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 5.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.4 | 5.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.4 | 3.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 8.7 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.4 | 4.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 8.0 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 1.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 3.7 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 5.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 5.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.3 | 4.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.3 | 2.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 2.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 4.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 0.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.3 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 3.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.3 | 3.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.3 | 0.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 5.5 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.3 | 4.6 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 4.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 3.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 0.6 | REACTOME TRIF MEDIATED TLR3 SIGNALING | Genes involved in TRIF mediated TLR3 signaling |
0.3 | 3.8 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 2.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.3 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 3.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 2.0 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 2.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.3 | 6.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 13.0 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 2.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 0.8 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
0.3 | 2.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 2.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.3 | 0.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.3 | 0.3 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.3 | 3.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 2.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 2.7 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 0.5 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.2 | 19.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 7.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 1.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.5 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 18.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.2 | 2.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 1.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.4 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.2 | 7.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 2.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.2 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 4.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.2 | 1.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 4.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.2 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 4.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 2.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 11.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 3.1 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 2.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 1.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 3.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.2 | 6.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 1.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 4.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 1.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.2 | 3.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 1.2 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 4.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.1 | 2.2 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
0.1 | 4.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 1.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 2.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 2.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 8.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 9.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.9 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 3.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 5.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 5.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 2.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 2.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.8 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 1.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 2.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 0.6 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.1 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 1.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 4.7 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 1.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.7 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 4.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 1.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |